Artigo Revisado por pares

Final Results Of Phase II Study Of Lenalidomide Plus Rituximab-CHOP21 In Elderly Untreated Diffuse Large B-Cell Lymphoma Focusing On The Analysis Of Cell Of Origin: REAL07 Trial Of The Fondazione Italiana Linfomi

2013; Elsevier BV; Volume: 122; Issue: 21 Linguagem: Inglês

10.1182/blood.v122.21.850.850

ISSN

1528-0020

Autores

Annalisa Chiappella, Silvia Franceschetti, Alessia Castellino, Angelo Michele Carella, Ileana Baldi, Manuela Zanni, Anna Marina Liberati, Michele Spina, Alessandra Tucci, Vincenzo Pavone, Anna Lia Molinari, Pier Luigi Zinzani, Flavia Salvi, Marcello Gaudiano, Pier Paolo Fattori, Alfonso Zaccaria, Barbara Botto, Angela Giovanna Congiu, Giovannino Ciccone, Marco Ladetto, Martin Dreyling, Gianluca Gaïdano, Giorgio Inghirami, Giuseppe Rossi, Umberto Vitolo,

Tópico(s)

Acute Lymphoblastic Leukemia research

Referência(s)
Altmetric
PlumX